Swissray takes steps to avoid stock delisting

Article

Swissray takes steps to avoid stock delistingDigital x-ray developer Swissray International of New York City will propose a reverse stock split at a shareholder meeting in late August. The split would bring the company into compliance with

Swissray takes steps to avoid stock delisting

Digital x-ray developer Swissray International of New York City will propose a reverse stock split at a shareholder meeting in late August. The split would bring the company into compliance with listing requirements on the NASDAQ stock exchange, according to documents Swissray filed with the Securities and Exchange Commission.

Swissray must maintain a minimum closing bid price of at least $1 a share to remain listed on the NASDAQ, but the company's stock price has been trading below that level for the last several months. NASDAQ gave the company until Aug. 6 to meet the minimum bid requirements, but the company's stock did not rise above $1 by the deadline and was trading at 41 in mid-August.

The reverse stock split would enable Swissray's stock to trade above the NASDAQ minimum bid requirements, according to the SEC documents. Swissray is pondering a split at a minimum ratio of 1-for-4 and a maximum ratio of 1-for-10. The split was scheduled to be proposed at a special shareholders meeting on Aug. 31 in New York City.

Recent Videos
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Related Content
© 2025 MJH Life Sciences

All rights reserved.